Jia X, Zhao Y, Carrico J, Brodtkorb TH, Mendelsohn AM, Lowry S, Feldman S, Wu JJ, Armstrong AW. Cost-effectiveness of tildrakizumab for the treatment of moderate-to-severe psoriasis in the United States. J Dermatolog Treat. 2020 Jun 30; 1-9.